FindTrial
Sign In

A multicenter real-world study of the multihomologic epigenetic characterization

A multicenter real-world study of the multihomologic epigenetic characterization

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036627
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder cancer

Interventions

Surgical treatment group:tumour removal
Non-surgical treatment group:Systemic cancer treatment

Sponsors

The Third Affiliated Hospital of the Second Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) The patient was diagnosed with gallbladder cancer by pathologic biopsy and could not undergo radical surgery or had undergone palliative tumor resection of the tumor; (2) The patient and family voluntarily participated in the study and signed an informed consent form and agreed to follow up, and (3) The patient had no significant contraindications.

Exclusion criteria

Exclusion criteria: (1) The patient refuses to sign informed consent and follow up, (2) The patient has a serious infectious disease such as syphilis or AIDS, and (3) The patient has a serious chronic disease other than cancer.

Design outcomes

Primary

MeasureTime frame
Genetic variation characteristics;Gene expression signature;Prognosis of treatment;—

Countries

China

Contacts

Public ContactXiaoqing Jiang

The Third Affiliated Hospital of the Second Military Medical University

jxq1225@sina.com+86 13801603438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026